Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T cell lymphoma
暂无分享，去创建一个
S. Ogawa | S. Demeyer | K. Jacobs | J. Cools | T. Tousseyn | N. Mentens | D. Nittner | D. Dierickx | C. Graux | K. Kataoka | M. Vanden Bempt | O. Gielen | Q. Van Thillo | K. Debackere | N. Meeuws | S. Provost